BRIEF published on 10/14/2024 at 18:05, 1 month 6 days ago Purchase of own shares by Jacques Bogart in September 2024 Stock Transactions Jacques Bogart Investment September 2024 Market Purchase LCL Deposit Account
BRIEF published on 10/14/2024 at 17:55, 1 month 6 days ago Monthly information on the voting rights of JACQUES BOGART Financial Information Share Capital Voting Rights Actions Jacques Bogart
BRIEF published on 09/26/2024 at 18:05, 1 month 24 days ago Jacques Bogart Announces H1 2024 Results: EBITDA Up by 13.9% EBITDA Net Loss Turnover Jacques Bogart H1 2024
PRESS RELEASE published on 09/26/2024 at 18:00, 1 month 24 days ago H1 2024 RESULTS BOGART reports H1 2024 results with turnover at €134.0 million (-2.6%) and EBITDA growth of 13.9%, driven by reorganisation and strong performance in Bogart Beauty Retail EBITDA Turnover Results BOGART H1 2024
BRIEF published on 09/16/2024 at 18:05, 2 months 4 days ago Declaration of Transactions in Own Shares Carried Out by Jacques Bogart Transactions Own Shares Purchase Jacques Bogart Walk
BRIEF published on 09/13/2024 at 19:35, 2 months 7 days ago Jacques Bogart: Monthly information on voting rights Voting Rights Capital Actions AMF JBOG
BRIEF published on 07/25/2024 at 18:05, 3 months 26 days ago Turnover for the first half of 2024: EUR 133.5 million Retail Cosmetics Turnover Fragrances BOGART
PRESS RELEASE published on 07/25/2024 at 18:00, 3 months 26 days ago H1 2024 turnover: EUR 133.5 million Bogart's H1 2024 revenues reached €139.3m, with Fragrances & Cosmetics at €26.4m (-5.0%) and Beauty Retail at €107.1m (-2.5%). Strategy includes new brand launches and margin expansion Revenues Strategy Cosmetics Fragrances BOGART
BRIEF published on 07/10/2024 at 18:20, 4 months 10 days ago Transactions on Jacques Bogart's own shares in June 2024 Own Shares Stock Transactions Jacques Bogart June 2024
BRIEF published on 07/10/2024 at 18:05, 4 months 10 days ago Monthly Information Relating to the Voting Rights of JACQUES BOGART Capital Monthly Information AMF Jacques Bogart Right To Vote
Published on 11/21/2024 at 14:00, 14 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 14 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 14 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 44 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 59 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 54 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
